Reported a positive interim safety update from the phase 2 IRENE trial at the 2021 San Antonio Breast Cancer Symposium.
News
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results ... - PR Newswire
- Significant New Clinical Trial Begins For Roche Alzheimer's Drug | Kaiser Health News
Biotech companies in particular often focus on developing therapies for ... Anthony Cantu, 31, counsels patients at a San Antonio health clinic ...
- Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
“In the fourth quarter of 2021 Puma executed on its key milestones, which included the presentation of data from the SUMMIT trial at the 2021 San ...
- Black Bird Biotech Posts Full MiteXstreamTM Biopesticide Efficacy Report - Big News Network.com
FLOWER MOUND, TX / ACCESSWIRE / March 3, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, ...
- Oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call ...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Q4 2021 Earnings Conference Call ... At the most recent San Antonio Breast Cancer Symposium in December, ...